acetylgalactosamine has been researched along with Virus Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balasubramanian, B; Easwaran, M; Meyyazhagan, A; Natarajan, J; Piramanayagam, S; Pushparaj, K; Thangamani, L | 1 |
| Dowdy, SF; Springer, AD | 1 |
2 review(s) available for acetylgalactosamine and Virus Diseases
| Article | Year |
|---|---|
GalNAc-siRNA conjugates: Prospective tools on the frontier of anti-viral therapeutics.
Topics: Acetylgalactosamine; Animals; Humans; RNA Interference; RNA, Small Interfering; Virus Diseases; Viruses | 2021 |
GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics.
Topics: Acetylgalactosamine; Asialoglycoprotein Receptor; Clinical Trials as Topic; Endocytosis; Endosomes; Gene Transfer Techniques; Glycoconjugates; Hepatocytes; Liver; Nanoparticles; Neoplasms; Parkinson Disease; RNA, Small Interfering; Virus Diseases | 2018 |